Transcriptional Analysis for Tuberculosis in Pregnant Women From the PRegnancy Associated Changes In Tuberculosis Immunology (PRACHITi) Study.
RNA signature
immunology
pregnancy
transcriptomics
tuberculosis
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
19 12 2022
19 12 2022
Historique:
received:
11
02
2022
pubmed:
11
6
2022
medline:
22
12
2022
entrez:
10
6
2022
Statut:
ppublish
Résumé
A new tuberculosis (TB) diagnostic cartridge assay, which detects a 3-gene TB signature in whole blood, was not diagnostic in women with maternal TB disease in India (area under the curve [AUC] = 0.72). In a cohort of pregnant women, we identified a novel gene set for TB diagnosis (AUC = 0.97) and one for TB progression (AUC = 0.96).
Identifiants
pubmed: 35686302
pii: 6605083
doi: 10.1093/cid/ciac437
pmc: PMC9761891
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2239-2242Subventions
Organisme : NICHD NIH HHS
ID : R01 HD081929
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI129854
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069465
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. A. G. receives support from the Gilead Foundation, the Makhija Foundation, and the Wyncote Foundation; reports grants or contracts unrelated to this work from NIH, Unitaid, and the Centers for Disease Control and Prevention; reports participation on a data and safety monitoring board or advisory board for the NIH/NIAID Advisory Council and Indo US Science Technology Governing Board; and reports a leadership or fiduciary role with the International Maternal Pediatric and Adolescent AIDS Clinical Trial Network TB Scientific Committee and World Health Organization Multidrug-Resistant Tuberculosis Guidelines Committee. J. S. M. reports grants or contracts unrelated to this work and support for attending meetings and/or travel from the NIH, paid to institution, and the Aurum Institute. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Références
PLoS One. 2014 Mar 21;9(3):e92308
pubmed: 24658103
Tuberculosis (Edinb). 2014 Dec;94(6):606-15
pubmed: 25621360
Am J Respir Crit Care Med. 2012 Apr 1;185(7):779-84
pubmed: 22161161
Sci Rep. 2020 May 25;10(1):8629
pubmed: 32451443
BMC Res Notes. 2021 Jun 30;14(1):247
pubmed: 34193258
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
Front Endocrinol (Lausanne). 2020 Feb 25;11:80
pubmed: 32161574
Lancet Respir Med. 2020 Apr;8(4):395-406
pubmed: 31958400
N Engl J Med. 2014 Jun 5;370(23):2211-8
pubmed: 24897084
Int J Infect Dis. 2020 Dec;101:235-242
pubmed: 33039610
J Anim Sci. 2019 Jul 30;97(8):3253-3261
pubmed: 31150538
J Infect Dis. 2013 Jan 15;207(2):340-50
pubmed: 23125442